Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Chem Biol
2012 Oct 19;710:1738-45. doi: 10.1021/cb300246j.
Show Gene links
Show Anatomy links
Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.
Duffy NH
,
Lester HA
,
Dougherty DA
.
???displayArticle.abstract???
The serotonin type 3 receptor (5-HT(3)R) is a ligand-gated ion channel found in the central and peripheral nervous systems. The 5-HT(3)R is a therapeutic target, and the clinically available drugs ondansetron and granisetron inhibit receptor activity. Their inhibitory action is through competitive binding to the native ligand binding site, although the binding orientation of the drugs at the receptor has been a matter of debate. Here we heterologously express mouse 5-HT(3)A receptors in Xenopus oocytes and use unnatural amino acid mutagenesis to establish a cation-π interaction for both ondansetron and granisetron to tryptophan 183 in the ligand binding pocket. This cation-π interaction establishes a binding orientation for both ondansetron and granisetron within the binding pocket.
Barnes,
The 5-HT3 receptor--the relationship between structure and function.
2009, Pubmed
Barnes,
The 5-HT3 receptor--the relationship between structure and function.
2009,
Pubmed
Beene,
Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.
2002,
Pubmed
,
Xenbase
de Lorenzi,
Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes.
1994,
Pubmed
Dougherty,
Cys-loop neuroreceptors: structure to the rescue?
2008,
Pubmed
Dougherty,
Physical organic chemistry on the brain.
2008,
Pubmed
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hibbs,
Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
2009,
Pubmed
Ito,
Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
1995,
Pubmed
Jensen,
3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.
2008,
Pubmed
Joshi,
Interactions of granisetron with an agonist-free 5-HT3A receptor model.
2006,
Pubmed
,
Xenbase
Kilpatrick,
1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.
1990,
Pubmed
Machu,
Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.
2011,
Pubmed
Maksay,
Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models.
2003,
Pubmed
Miles,
A coupled array of noncovalent interactions impacts the function of the 5-HT3A serotonin receptor in an agonist-specific way.
2012,
Pubmed
,
Xenbase
Nichols,
Serotonin receptors.
2008,
Pubmed
Niesler,
Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.
2007,
Pubmed
Nowak,
In vivo incorporation of unnatural amino acids into ion channels in Xenopus oocyte expression system.
1998,
Pubmed
,
Xenbase
Ricci,
Reactions between organomagnesium reagents and nitroarenes: past, present, and future.
2003,
Pubmed
Rojas,
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
2008,
Pubmed
Thompson,
The structural basis of function in Cys-loop receptors.
2010,
Pubmed
Thompson,
The 5-HT3 receptor as a therapeutic target.
2007,
Pubmed
Thompson,
Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.
2005,
Pubmed
Thompson,
5-HT3 receptors.
2006,
Pubmed
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
Wyllie,
Taking the time to study competitive antagonism.
2007,
Pubmed
Xiu,
Nicotine binding to brain receptors requires a strong cation-pi interaction.
2009,
Pubmed
,
Xenbase
Yan,
Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.
2005,
Pubmed
